Atlas Trials

A Phase 1 Safety Study in Adults With Schizophrenia

Clinical trial NCT02804568 · COMPLETED

Trial details

NCT number
NCT02804568
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2016-06-01
Primary completion
2016-08-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.